Stock Recommendation: NTLA/ Intellia Therapeutics, Inc

NTLA/ Intellia Therapeutics, Inc

Projected Stock Price:$69.28 ↑229.88%

The average one-year price target for Intellia Therapeutics, Inc. is$69.28. The forecasts range from a low of $24.24 to a high of$151.20.

Projected Revenue.

18 MM 1162.00%

To come up with their price target, an analyst must first determinethe stock’s fair value. A common way that analysts calculate theprice target for a stock is by creating a multiple of the price-toearnings ratio. To calculate this, analysts will multiply the marketprice by the company’s trailing 12-month earnings.

Projected Earnings Per Share:-1.54 ↓-1.62%

For a company with a 12-month earnings growth rate of 10 percentand a stock that is trading at $30, the multiplier would be 1.10.Based on this information, a possible price target would be:1.10x30 =$33.

Trade Recommendation : Long

View Next

Analyzing the Fed Easing Cycle

Given the uncertainty surrounding both the Federal Reserve's policy direction and the upcoming U.S. presidential election, it is advisable for portfolios to prioritize quality—favoring large-cap companies over small- and mid-cap firms.